Eli Lilly & Co. (NYSE:LLY)

graph

8 Stocks on the Move After ASCO Cancer Abstracts

The American Society of Clinical Oncology (ASCO) is in the process of setting up for its annual meeting in Chicago. In this meeting, companies and cancer drug developers will share ...
Read Full Story »
dominoes collapsing

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

Tuesday's nice rally notwithstanding, some market pros are getting nervous, and with good reason. Despite the inexorable move higher in the markets since the lows in February, there is a ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

Stocks were indicated to open higher on Tuesday in what looks like a broad rally. With the Dow still down about 500 points from the April highs, investors still seem ...
Read Full Story »
Medicine pills

What to Expect When Eli Lilly Reports Earnings

Eli Lilly and Co. (NYSE: LLY) is set to release its first-quarter earnings report before the markets open on Tuesday. Thomson Reuters has consensus estimates of $0.85 in earnings per share ...
Read Full Story »
dividends

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

We are just about to wrap up the first quarter, and we could very well end where we started the year. After a brutal January and February sell-off that took ...
Read Full Story »
graph

5 Credit Suisse Focus List Stocks With the Most Upside

With the new quarter set to begin and the new earnings season about to kick off, many Wall Street firms covered by 24/7 Wall St. are adjusting their top stocks lists ...
Read Full Story »
open happiness

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

Though the markets have fought their way back to even after a horrible start to the year, one very interesting anomaly continues to show up. According to Merrill Lynch, for the ...
Read Full Story »
analysis

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

Now that stocks have charged back from the depths of the January and February selling, the Dow Jones Industrial Average (DJIA) and S&P 500 managed to come back to positive ...
Read Full Story »
Stock Price

The 52-Week Low Club for Thursday

March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday's session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped another 11.4% ...
Read Full Story »
Stock Price

The 52-Week Low Club for Tuesday

March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday's session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more ...
Read Full Story »
Medicine pills

Jefferies Top Drug Stocks for the Rest of 2016

One key analyst firm is continuing to look at which companies in the health care space are going to return the most in 2016. For the most part, Jefferies maintained ...
Read Full Story »
Prescription drugs

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

One sector that has lagged dramatically over the past year, although it is very defensive and pays good dividends, is health care — specifically the big pharmaceutical stocks. The constant ...
Read Full Story »
Medicine pills

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

Despite all the negative chatter about drug pricing, the fact of the matter is that the top companies not only produce drugs that save and change lives, they consistently reinvest ...
Read Full Story »
Prescription drugs

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them ...
Read Full Story »
3M_wordmark

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

If you remember the dark days of 2009, then it may surprise you to know that currently Wall Street strategists and those who prognosticate the future are as bearish as ...
Read Full Story »